Posted in | News | Composites

Cytec Holds Successful Rail Symposium at National Composites Centre

Cytec Industrial Materials, in conjunction with the Rail Alliance, recently held a successful rail symposium at the National Composites Centre (NCC), Bristol - UK.

Dr Richard Horn, Industrial Market Sector Manager for Cytec Industrial Materials, gave a presentation on the benefits of using advanced lightweight composite materials for railway rolling stock, particularly rail interiors.

Simon Howarth of Ipeco Composites discussed manufacturing procedures and focused on the application of Cytec’s composites for standbacks produced by Ipeco for Bombardier Transportation’s Class 379 Electrostar EMU passenger trains, which are currently being run on the Stansted Airport to London link. Bristol UK based Ipeco Composites manufactured 960 standbacks for Bombardier Transportation, UK using Cytec’s MTM®82S-C phenolic prepreg, which meets the requirements of BS6853 Cat.1a, the standard governing the fire performance of rail rolling stock.

Neil Bates from Creactive Design gave a vision of the future when he presented a lightweight, modular vehicle concept for the manufacture of composite railcars.

Nigel Keen of the NCC said; “This was a really good event and we see this as the start of the NCC working within the rail industry.” To complete the presentation, delegates were given an opportunity to tour the NCC.

Commenting in general, both Simon Howarth (Ipeco) and Neil Bates (Creactive Design) said it was an excellent event with good technical interactions and the NCC is a facility the rail industry will greatly value.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.